Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1.315
1.264 stocks
| Empresa | Último precio | Cambio de precio | Capitalización bursátil | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1.196,03 |
+0,9%
|
$1,13 T |
|
|
|
Johnson & Johnson
JNJ
|
$263,4 |
+1,6%
|
$634,06 B |
|
|
|
Merck & Co Inc
MRK
|
$131,07 |
+0,5%
|
$323,72 B |
|
|
|
Roche Holding AG
ROG
|
CHf324,9 |
+4,1%
|
$321,94 B |
|
|
|
Novartis AG
NOVN
|
CHf127,34 |
-0,3%
|
$297,51 B |
|
|
|
AstraZeneca PLC
AZN
|
12.670 |
-0,1%
|
$261,74 B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr324,15 |
+1,2%
|
$218,27 B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$34,04 |
-1%
|
$176,80 B |
|
|
|
Pfizer Inc
PFE
|
$24,54 |
-0,2%
|
$139,86 B |
1.259 resultados ocultos
Crea una cuenta gratuita para desbloquear acceso adicional y mejora para ver todos los resultados
Crear cuenta gratuita
